Profile for NeuroBo Pharmaceuticals Inc. (NRBO)

$ 5.60   0.13 (+2.38%) Volume: 8.92k 1:55 PM EDT Sep 24, 2020
Business Description:
Gemphire Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease.
Address: 200 Berkeley Street, Office 19th Floor, Boston, MA, US, 02116
Telephone: +1 857 702-9600 Website: https://www.neurobopharma.com
Facsimile: N/A Email: [email protected]
Details
CEO: Richard Kang
Employees: 12 Market Cap: 91.99m
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1638287
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)